Healthcare Costs for Mitochondrial Disease Are Comparable to Those for ALS and MS

Patients with mitochondrial disease have a significantly higher cost burden compared with the general population, according to the results of a recent retrospective claims analysis.  See the report here.

2019-01-25T15:32:44+00:00
%d bloggers like this: